About this trial
The RW-HOMECARE study is a prospective, longitudinal, real-world pilot trial designed to assess the impact of proposing the Monka digital solution to non-professional caregivers of patients discharged from emergency or short-stay units. The primary objective is to measure changes in caregiver burden using the ZBI-12 scale at baseline, 30 days, and 90 days. Secondary objectives include evaluating caregivers' physical and mental quality of life (SF-12), patient frailty (Clinical Frailty Scale), and the incidence of adverse events such as emergency visits, unplanned hospitalizations, falls, institutionalization, and death within 90 days. The study also examines the usability, acceptability, and satisfaction with Monka digital solution through standardized questionnaires, the correlation between algorithm-generated vulnerability scores and established measures, and reasons for non-adoption.
Eligible dyads (patient and caregiver) are recruited at discharge from emergency or short-stay units. After informed consent, caregivers receive free access to Monka digital solution for 3 months, along with a user guide. Follow-up assessments are conducted by phone at Day 30 and Day 90 (±14 days). All interventions by the coordinating nurse are tracked and analyzed quantitatively and qualitatively.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Person aged 18 or over, treated in the Emergency Department or Emergency Beds
Affiliated with Social Security
Having an adult non-professional relative helping them with one or more activities of daily living
Having a medical decision to return home within the next 72 hours
Disqualifiers
Non-French speakers
People living in a medical institution or scheduled for institutionalization within the next 3 months
People receiving home hospitalization (HAD) or palliative care at home
People under legal protection, deprived of their liberty, or under legal guardianship (tutelage or curatelle) FOR THE CAREGIVER
Trial design
Single group
Treatments tested in this trial
Caregivers supporting vulnerable patients and using the MyMonka solution.
Other interventionTesting of the MyMonka solution; Response to questionnaires during the follow-up period on quality of life and burden measurement
Treatment groups
Trial outcomes
Primary outcomes
Change in the score on the 12-item Zarit Burden Interview questionnaire (ZBI-12, Appendix 1), measured on days 0, 30, and 90, among family caregivers participating in the study.
Secondary outcomes
Change in the physical and mental quality of life of caregivers, expressed as the difference between SF-12 questionnaire scores at baseline, on day 30, and on day 90.
Change in patient frailty expressed as the difference between the Clinical Frailty Scale score obtained at inclusion and on day 90.
Percentage of people affected by the following adverse events within three months of returning home: new emergency room visits, unscheduled hospitalizations and their duration, falls, home hospitalizations, institutionalization, and death.
Evaluation of the use, acceptability, usability, and impact of the Monka digital solution for caregivers through intervention tracking, algorithm-based vulnerability assessment, and standardized questionnaires over a 90-day period.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Fondation Hôpital Saint-Joseph
Lead sponsor
Monka Care
Collaborator